These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 14760281)
1. When to use bisphosphonates. Bachrach LK; Gandrud LM J Pediatr; 2004 Feb; 144(2):285; author reply 285-6. PubMed ID: 14760281 [No Abstract] [Full Text] [Related]
2. Bisphosphonates for osteoporosis--where do we go from here? Whitaker M; Guo J; Kehoe T; Benson G N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168 [No Abstract] [Full Text] [Related]
3. [Treatment with bisphosphonates: daily or once-weekly oral administration and intravenous injection]. Kitahama S; Ishii T; Wada S Clin Calcium; 2005 Apr; 15(4):649-54. PubMed ID: 15802779 [TBL] [Abstract][Full Text] [Related]
4. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy. Miller PD Clin Ther; 2005 Apr; 27(4):361-76. PubMed ID: 15922811 [TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis. Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613 [TBL] [Abstract][Full Text] [Related]
6. Improving compliance and persistence with bisphosphonate therapy for osteoporosis. Emkey RD; Ettinger M Am J Med; 2006 Apr; 119(4 Suppl 1):S18-24. PubMed ID: 16563937 [TBL] [Abstract][Full Text] [Related]
7. Who will benefit from antiresorptive treatment (bisphosphonates)? Papapoulos SE Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190 [TBL] [Abstract][Full Text] [Related]
8. Corticosteroids: no drug prevention of fractures needed. Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563 [TBL] [Abstract][Full Text] [Related]
9. Issues in designing and testing a "cure" for osteoporosis. Cummings S J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):408. PubMed ID: 15758283 [No Abstract] [Full Text] [Related]
10. An integrated approach: bisphosphonate management for the treatment of osteoporosis. Owens G; Jackson R; Lewiecki EM Am J Manag Care; 2007 Dec; 13 Suppl 11():S290-308; quiz S309-12. PubMed ID: 18095779 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate use in children with pediatric osteoporosis and other bone conditions. Szalay EA J Pediatr Rehabil Med; 2014; 7(2):125-32. PubMed ID: 25096864 [TBL] [Abstract][Full Text] [Related]
12. Is treatment of early postmenopausal women with bisphosphonates justified? Epstein S Int J Clin Pract; 2007 Jun; 61(6):963-71. PubMed ID: 17504359 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy. J Support Oncol; 2006 Feb; 4(2):99-100. PubMed ID: 16499137 [No Abstract] [Full Text] [Related]
14. [Evaluation of osteoporosis treatment efficacy by bone mass measurement]. Miki T; Tomiyoshi Y Clin Calcium; 2004 Dec; 14(12):19-26. PubMed ID: 15577169 [TBL] [Abstract][Full Text] [Related]
16. Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study. van den Boogaard CH; Breekveldt-Postma NS; Borggreve SE; Goettsch WG; Herings RM Curr Med Res Opin; 2006 Sep; 22(9):1757-64. PubMed ID: 16968579 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacotherapy of osteoporosis: prospects of bisphosphonates]. Nasonov EL; Skripnikova IA; Benevolenskaia LI; Nasonova VA Klin Med (Mosk); 1996; 74(9):16-22. PubMed ID: 9121080 [No Abstract] [Full Text] [Related]
18. Osteoporosis in men. Joy M N Engl J Med; 2008 Aug; 359(8):868; author reply 869. PubMed ID: 18724403 [No Abstract] [Full Text] [Related]
19. Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis. Doga M; Bonadonna S; Burattin A; Carpinteri R; Manelli F; Giustina A Front Horm Res; 2002; 30():150-64. PubMed ID: 11892263 [No Abstract] [Full Text] [Related]